litlas
Log inCreate account

Robert B. Jenkins

Active 1989–2025

Also published as
Robert B Jenkins
226
Papers
57,998
Citations
118
h-index
222
i10-index

Citations

Citations per year for Robert B. Jenkins1961: 1 citations1974: 1 citations1986: 2 citations1990: 4 citations1991: 3 citations1992: 20 citations1993: 40 citations1994: 63 citations1995: 63 citations1996: 59 citations1997: 80 citations1998: 106 citations1999: 132 citations2000: 205 citations2001: 198 citations2002: 222 citations2003: 262 citations2004: 271 citations2005: 269 citations2006: 370 citations2007: 359 citations2008: 371 citations2009: 384 citations2010: 417 citations2011: 401 citations2012: 372 citations2013: 388 citations2014: 450 citations2015: 553 citations2016: 530 citations2017: 606 citations2018: 467 citations2019: 1,582 citations2020: 1,661 citations2021: 1,563 citations2022: 1,164 citations2023: 833 citations2024: 1,247 citations2025: 457 citations2026: 16 citations1962–1973: no citations, so these years are not shown1975–1985: no citations, so these years are not shown1987–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 6,362 citing papers, 30.4% of this breakdownChina: 2,004 citing papers, 9.6% of this breakdownGermany: 1,212 citing papers, 5.8% of this breakdownUnited Kingdom: 1,201 citing papers, 5.7% of this breakdownCanada: 958 citing papers, 4.6% of this breakdownItaly: 950 citing papers, 4.5% of this breakdownFrance: 725 citing papers, 3.5% of this breakdownNetherlands: 640 citing papers, 3.1% of this breakdownJapan: 545 citing papers, 2.6% of this breakdownSwitzerland: 533 citing papers, 2.6% of this breakdownSpain: 499 citing papers, 2.4% of this breakdownAustralia: 486 citing papers, 2.3% of this breakdown
0%30.4%Other 22.9%

Institutions

Fields

  • Medicine60.4%
  • Biochemistry, Genetics and Molecular Biology32.1%
  • Neuroscience2.2%
  • Immunology and Microbiology1.5%
  • Computer Science1.4%
  • Engineering0.6%
  • Other1.8%

Topics

  • Glioma Diagnosis and Treatment8.5%
  • HER2/EGFR in Cancer Research3.9%
  • Cancer Genomics and Diagnostics3%
  • Breast Cancer Treatment Studies2.9%
  • Prostate Cancer Treatment and Research2.5%
  • Cancer-related molecular mechanisms research2.4%
  • Other76.8%

Coauthors

All papers

Open in search
  1. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

    Authors: Antonio C. Wolff, M. Elizabeth Hammond, Kimberly H. Allison, Brittany Harvey, Pamela B. Mangu, John M.S. Bartlett, Michael Bilous, Ian O. Ellis, Patrick L. Fitzgibbons, Wedad Hanna, Robert B. Jenkins, Michael F. Press, Patricia A. Spears, Gail H. Vance, Giuseppe Viale, Lisa M. McShane, Mitch Dowsett - Archives of Pathology & Laboratory Medicine 2018 cited by 2,454

  2. Glioma Groups Based on 1p/19q,IDH, andTERTPromoter Mutations in Tumors

    Authors: Jeanette E. Eckel‐Passow, Daniel H. Lachance, Annette M Molinaro, Kyle M. Walsh, Paul A. Decker, Hugues Sicotte, Melike Pekmezci, Terri Rice, Matt Kosel, Ivan Smirnov, Gobinda Sarkar, Alissa Caron, Thomas M. Kollmeyer, Corinne Praska, Anisha R. Chada, Chandralekha Halder, Helen M. Hansen, Lucie McCoy, Paige M. Bracci, Roxanne Marshall, Shichun Zheng, Gerald F. Reis, Alexander R. Pico, Brian Patrick O’Neill, Jan C. Buckner, Caterina Giannini, Jason T. Huse, Arie Perry, Tarık Tihan, Mitchel S. Berger, Susan M. Chang, Michael D. Prados, Joseph L. Wiemels, John K. Wiencke, Margaret Wrensch, Robert B. Jenkins - New England Journal of Medicine 2015 cited by 1,984

  3. Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

    Authors: Edward H. Romond, Edith A. Perez, John Bryant, Vera J. Suman, Charles E. Geyer, Nancy E. Davidson, Elizabeth Tan-Chiu, Silvana Martino, Soonmyung Paik, Peter A. Kaufman, Sandra M. Swain, Thomas M. Pisansky, Louis Fehrenbacher, Leila A. Kutteh, Victor G. Vogel, Daniel W. Visscher, Greg Yothers, Robert B. Jenkins, Ann Brown, Shaker R. Dakhil, Eleftherios P. Mamounas, Wilma L. Lingle, Pamela Klein, James N. Ingle, Norman Wolmark - New England Journal of Medicine 2005 cited by 5,353

  4. Association of Maximal Extent of Resection of Contrast-Enhanced and Non–Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma

    Authors: Annette M. Molinaro, Shawn L. Hervey‐Jumper, Ramin A. Morshed, Jacob S. Young, Seunggu J. Han, Pranathi Chunduru, Yalan Zhang, Joanna J. Phillips, Anny Shai, Marisa Lafontaine, Jason C. Crane, Ankush Chandra, Patrick M. Flanigan, Arman Jahangiri, Gino Cioffi, Quinn T. Ostrom, John E. Anderson, Chaitra Badve, Jill S. Barnholtz‐Sloan, Andrew E. Sloan, Bradley J. Erickson, Paul A. Decker, Matthew Kosel, Daniel H. Lachance, Jeanette E. Eckel‐Passow, Robert B. Jenkins, Javier Villanueva‐Meyer, Terri Rice, Margaret Wrensch, John K. Wiencke, Nancy Ann Oberheim Bush, Jennie Taylor, Nicholas Butowski, Michael D. Prados, Jennifer Clarke, Susan M. Chang, Edward F. Chang, Manish K. Aghi, Philip V. Theodosopoulos, Michael W. McDermott, Mitchel S. Berger - JAMA Oncology 2020 cited by 643

  5. Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions

    Authors: Julie J. Miller, L. Nicolas Gonzalez Castro, Samuel K. McBrayer, Michael Weller, Timothy F. Cloughesy, Jana Portnow, Ovidiu C. Andronesi, Jill S. Barnholtz‐Sloan, Brigitta G. Baumert, Mitchel S. Berger, Wenya Linda Bi, Ranjit S. Bindra, Daniel P. Cahill, Susan M. Chang, J Costello, Craig Horbinski, Raymond Y. Huang, Robert B. Jenkins, Keith L. Ligon, Ingo K. Mellinghoff, Burt Nabors, Michael Platten, David A. Reardon, Diana D. Shi, David Schiff, Wolfgang Wick, Hai Yan, Andreas von Deimling, Martin J. van den Bent, William G. Kaelin, Patrick Y. Wen - Neuro-Oncology 2022 cited by 237

  6. Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study

    Authors: Martin J. van den Bent, C. Mircea S. Tesileanu, Wolfgang Wick, Marc Sanson, Alba A. Brandes, Paul M. Clément, S. C. Erridge, Michael A. Vogelbaum, Anna K. Nowak, Jean Français Baurain, Warren Mason, Helen Wheeler, Olivier Chinot, Sanjeev Gill, Matthew Griffin, Leland Rogers, Walter Taal, Roberta Rudà, Michael Weller, Catherine McBain, Jaap C. Reijneveld, Roelien H. Enting, Francesca Caparrotti, Thierry Lesimple, Susan Clenton, Anja Gijtenbeek, Elizabeth Lim, Ulrich Herrlinger, Peter Hau, F. Dhermain, Iris de Heer, Kenneth Aldape, Robert B. Jenkins, Hendrikus J. Dubbink, Johan M. Kros, Pieter Wesseling, Sarah Nuyens, Vassilis Golfinopoulos, Thierry Gorlia, Pim J. French, Brigitta G. Baumert - The Lancet Oncology 2021 cited by 327

  7. cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”

    Authors: Daniel J. Brat, Kenneth Aldape, Howard Colman, Eric C. Holland, David N. Louis, Robert B. Jenkins, Bette K. Kleinschmidt‐DeMasters, Arie Perry, Guido Reifenberger, Roger Stupp, Andreas von Deimling, Michael Weller - Acta Neuropathologica 2018 cited by 906

  8. cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas

    Authors: Daniel J. Brat, Kenneth Aldape, Howard Colman, Dominique Figrarella-Branger, Gregory N. Fuller, Caterina Giannini, Eric C. Holland, Robert B. Jenkins, Bette K. Kleinschmidt‐DeMasters, Takashi Komori, Johan M. Kros, David N. Louis, Catriona McLean, Arie Perry, Guido Reifenberger, Chitra Sarkar, Roger Stupp, Martin J. van den Bent, Andreas von Deimling, Michael Weller - Acta Neuropathologica 2020 cited by 530

  9. Generative Adversarial Networks to Synthesize Missing T1 and FLAIR MRI Sequences for Use in a Multisequence Brain Tumor Segmentation Model

    Authors: Gian Marco Conte, Alexander D. Weston, David C. Vogelsang, Kenneth A. Philbrick, Jason Cai, Maurizio Barbera, Francesco Sanvito, Daniel H. Lachance, Robert B. Jenkins, W. Oliver Tobin, Jeanette E. Eckel‐Passow, Bradley J. Erickson - Radiology 2021 cited by 125

  10. Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

    Authors: Antonio C. Wolff, M. Elizabeth Hammond, David G. Hicks, Mitch Dowsett, Lisa M. McShane, Kimberly H. Allison, D. Craig Allred, John M.S. Bartlett, Michael Bilous, Patrick L. Fitzgibbons, Wedad Hanna, Robert B. Jenkins, Pamela B. Mangu, Soonmyung Paik, Edith A. Perez, Michael F. Press, Patricia A. Spears, Gail H. Vance, Giuseppe Viale, Daniel F. Hayes - Archives of Pathology & Laboratory Medicine 2013 cited by 4,061

  11. Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma

    Authors: Rachael A. Vaubel, Shulan Tian, Dioval Remonde, Mark A. Schroeder, Ann C. Mladek, Gaspar J. Kitange, Alissa Caron, Thomas M. Kollmeyer, Rebecca Grove, Sen Peng, Brett L. Carlson, J. Daniel, Gobinda Sarkar, Lisa Evers, Paul A. Decker, Huihuang Yan, Harshil Dhruv, Michael E. Berens, Qianghu Wang, Bianca M. Marin, Eric W. Klee, Andrea Califano, Daniel H. Lachance, Jeanette E. Eckel‐Passow, Roel G.W. Verhaak, Erik P. Sulman, Terry C. Burns, Fredrick B. Meyer, Brian Patrick O’Neill, Nhan L. Tran, Caterina Giannini, Robert B. Jenkins, Ian F. Parney, Jann N. Sarkaria - Clinical Cancer Research 2019 cited by 239

  12. Genetics of adult glioma

    Authors: McKinsey L. Goodenberger, Robert B. Jenkins - Cancer Genetics 2012 cited by 844

  13. Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy

    Authors: Nicholas Erho, Anamaria Crisan, Ismael A. Vergara, Anirban P. Mitra, Mercedeh Ghadessi, Christine Buerki, Eric J. Bergstralh, Thomas M. Kollmeyer, Stephanie Fink, Zaid Haddad, Benedikt Zimmermann, Thomas Sierocinski, Karla V. Ballman, Timothy J. Triche, Peter C. Black, R. Jeffrey Karnes, George G. Klee, Elai Davicioni, Robert B. Jenkins - PLoS ONE 2013 cited by 665

  14. The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression

    Authors: Kui Ming Chan, Dong Fang, Haiyun Gan, Rintaro Hashizume, Chuanhe Yu, Mark A. Schroeder, Nalin Gupta, Sabine Mueller, C. David James, Robert B. Jenkins, Jann N. Sarkaria, Zhiguo Zhang - Genes & Development 2013 cited by 706

  15. Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402

    Authors: Gregory Cairncross, Meihua Wang, Edward Shaw, Robert B. Jenkins, David Brachman, Jan C. Buckner, Karen Fink, Luís Souhami, Normand Laperrière, Walter Curran, Minesh P. Mehta - Journal of Clinical Oncology 2012 cited by 1,163

  16. Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

    Authors: Martin J. van den Bent, Brigitta G. Baumert, Sara Erridge, Michael A. Vogelbaum, Anna K. Nowak, Marc Sanson, Alba A. Brandes, Paul M. Clément, Jean Français Baurain, Warren Mason, Helen Wheeler, Olivier Chinot, Sanjeev Gill, Matthew Griffin, David Brachman, Walter Taal, Roberta Rudà, Michael Weller, Catherine McBain, Jaap C. Reijneveld, Roelien H. Enting, Damien C. Weber, Thierry Lesimple, Susan Clenton, Anja Gijtenbeek, S. Pascoe, Ulrich Herrlinger, Peter Hau, F. Dhermain, Irene van Heuvel, Roger Stupp, Ken Aldape, Robert B. Jenkins, Hendrikus J. Dubbink, Winand N.M. Dinjens, Pieter Wesseling, Sarah Nuyens, Vassilis Golfinopoulos, Thierry Gorlia, Wolfgang Wick, Johan M. Kros - The Lancet 2017 cited by 397

  17. The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex

    Authors: John R. Prensner, Matthew K. Iyer, Anirban Sahu, Irfan A. Asangani, Qi Cao, Lalit R. Patel, Ismael A. Vergara, Elai Davicioni, Nicholas Erho, Mercedeh Ghadessi, Robert B. Jenkins, Timothy J. Triche, Rohit Malik, Rachel Bedenis, Natalie McGregor, Teng Ma, Wei Chen, Sumin Han, Xiaojun Jing, Xuhong Cao, Xiaoju Wang, Benjamin C. Chandler, Wei Yan, Javed Siddiqui, Lakshmi P. Kunju, Saravana M. Dhanasekaran, Kenneth J. Pienta, Felix Y. Feng, Arul M. Chinnaiyan - Nature Genetics 2013 cited by 683

  18. Survival and low-grade glioma: the emergence of genetic information

    Authors: Elizabeth B. Claus, Kyle M. Walsh, John K. Wiencke, Annette M. Molinaro, Joseph L. Wiemels, Joellen M. Schildkraut, Melissa L. Bondy, Mitchel S. Berger, Robert B. Jenkins, Margaret Wrensch - Neurosurgical FOCUS 2015 cited by 449

  19. Radiogenomics to characterize regional genetic heterogeneity in glioblastoma

    Authors: Leland Hu, Shuluo Ning, Jennifer Eschbacher, Leslie C. Baxter, Nathan Gaw, Sara Ranjbar, Jonathan D. Plasencia, Amylou C. Dueck, Sen Peng, Kris A. Smith, Peter Nakaji, John P. Karis, C. Chad Quarles, Teresa Wu, Joseph C. Loftus, Robert B. Jenkins, Hugues Sicotte, Thomas M. Kollmeyer, Brian Patrick O’Neill, William F. Elmquist, Joseph M. Hoxworth, David Frakes, Jann N. Sarkaria, Kristin R. Swanson, Nhan L. Tran, Jing Li, J. Ross Mitchell - Neuro-Oncology 2016 cited by 226

  20. The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer

    Authors: Dimple Chakravarty, Andrea Sboner, Sujit S. Nair, Ευγενία Γιαννοπούλου, Ruohan Li, Sven Hennig, Juan Miguel Mosquera, Jonathan Pauwels, Kyung Park, Myriam Kossaï, Theresa Y. MacDonald, Jacqueline Fontugne, Nicholas Erho, Ismael A. Vergara, Mercedeh Ghadessi, Elai Davicioni, Robert B. Jenkins, Nallasivam Palanisamy, Zhengming Chen, Shinichi Nakagawa, Tetsuro Hirose, Neil H. Bander, Himisha Beltran, Archa H. Fox, Olivier Elemento, Mark A. Rubin - Nature Communications 2014 cited by 630

  21. Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis

    Authors: Bora Gürel, Tsuyoshi Iwata, Cheryl M. Koh, Robert B. Jenkins, Fusheng Lan, Chi V. Dang, Jessica Hicks, James Morgan, Toby C. Cornish, Siobhan Sutcliffe, William B. Isaacs, Jun Luo, Angelo M. De Marzo - Modern Pathology 2008 cited by 448

  22. A noncoding single-nucleotide polymorphism at 8q24 drives IDH1 -mutant glioma formation

    Authors: Connor Yanchus, Kristen Drucker, Thomas M. Kollmeyer, Ricky Tsai, Warren Winick‐Ng, Minggao Liang, Ahmad Malik, Judy Pawling, Silvana B. De Lorenzo, Asma Ali, Paul A. Decker, Matt Kosel, Arijit Panda, Khalid N. Al‐Zahrani, Lingyan Jiang, Jared Browning, Christopher Lowden, Michael J. Geuenich, J. Javier Hernández, Jessica Gosio, Musaddeque Ahmed, Sampath K. Loganathan, Jacob M. Berman, Daniel Trcka, Kulandaimanuvel Antony Michealraj, Jérôme Fortin, Brittany B. Carson, Ethan W. Hollingsworth, Sandra Jacinto, Parisa Mazrooei, Lily Zhou, Andrew Elia, Mathieu Lupien, Housheng Hansen He, Daniel J. Murphy, Liguo Wang, Alexej Abyzov, James W. Dennis, Philipp G. Maass, Kieran R. Campbell, Michael D. Wilson, Daniel H. Lachance, Margaret Wrensch, John K. Wiencke, Tak W. Mak, L Pennacchio, Diane E. Dickel, Axel Visel, Jeffrey L. Wrana, Michael D. Taylor, Gelareh Zadeh, Peter B. Dirks, Jeanette E. Eckel‐Passow, Liliana Attisano, Ana Pombo, Cristiane M. Ida, Evgeny Z. Kvon, Robert B. Jenkins, Daniel Schramek - Science 2022 cited by 69

  23. ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer

    Authors: Laura Cato, Jonas de Tribolet-Hardy, Irene Lee, Jaice T. Rottenberg, Ilsa M. Coleman, Diana Melchers, René Houtman, Tengfei Xiao, Wěi Li, Takuma Uo, Shihua Sun, Nane C Kuznik, Bettina Göppert, Fatma Özgün, Martin E. van Royen, Adriaan B. Houtsmuller, Raga Vadhi, Prakash K. Rao, Lewyn Li, Steven P. Balk, Robert B. Den, Bruce J. Trock, R. Jeffrey Karnes, Robert B. Jenkins, Eric A. Klein, Elai Davicioni, Friederike J. Gruhl, Henry W. Long, X. Shirley Liu, Andrew C.B. Cato, Nathan A. Lack, Peter S. Nelson, Stephen R. Plymate, Anna C. Groner, Myles Brown - Cancer Cell 2019 cited by 169

  24. CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design

    Authors: Kurt A. Jaeckle, Karla V. Ballman, Martin J. van den Bent, Caterina Giannini, Evanthia Galanis, Paul D. Brown, Robert B. Jenkins, J. Gregory Cairncross, Wolfgang Wick, Michael Weller, Kenneth Aldape, Jesse G Dixon, S. Keith Anderson, Jane H. Cerhan, Jeffrey S. Wefel, Martin Klein, Stuart A. Grossman, David Schiff, Jeffrey J. Raizer, F. Dhermain, Donald G. Nordstrom, Patrick J. Flynn, Michael A. Vogelbaum - Neuro-Oncology 2020 cited by 115